Schisandra is the five-flavor berry of an East Asian vine, valued for centuries as a stamina- and stress-supporting adaptogen. Its lignans act mainly as antioxidants and switch on the body's own protective and detoxifying systems. Evidence is uneven: animal liver data are fairly consistent, human research sparse. Inexpensive and well tolerated; can change how the liver processes medications. (Full Review)

Protocol

Standard dosing (whole berry / extract)

0.5–3 g dried berry daily

Or standardized extracts providing the equivalent, often standardized to schisandrin or total lignan content; tincture and decoction also used.

Best time of day

Morning or early afternoon

Mild stimulating, CNS-active nature; earlier dosing avoids interfering with sleep.

Single versus split dosing

Split, twice daily with meals

Short half-life favors split dosing to maintain exposure and reduce per-dose gastrointestinal load.

Time to effect

Liver-enzyme & metabolic changes

8–12 weeks

Assessed over this window in trials.

Menopausal-symptom benefit

12 weeks

Measured at 12 weeks in the menopausal-symptom trial.

Subjective stress/energy effects

Days to weeks

Reported within days to weeks, if present.

Benefits

Medium: Hepatoprotection; menopausal symptom relief

Low: Glycemic control; physical endurance & anti-fatigue

Speculative: Cognitive function & neuroprotection; muscle preservation

Contraindications

Pregnant women

Active peptic ulcer disease or severe acid reflux

Epilepsy or uncontrolled seizure disorders

Organ-transplant recipients on immunosuppressants (unless supervised)

Significant liver disease (decompensated cirrhosis, Child-Pugh Class C) without medical oversight

Key Interactions

Immunosuppressants (tacrolimus, sirolimus, cyclosporine)

CYP3A4-substrate prescription drugs (simvastatin, calcium-channel blockers, midazolam, some chemotherapy agents)

CYP3A4-inducing or -inhibiting agents (rifampicin, ketoconazole, ritonavir, grapefruit juice)

Over-the-counter medications (acetaminophen/paracetamol, NSAIDs such as ibuprofen)

Supplements with additive liver or sedative effects (milk thistle, kava, valerian, Rhodiola, ashwagandha)

Blood-glucose-lowering drugs (metformin, sulfonylureas, insulin)

Risk & Side Effects

Medium: Drug–herb interactions via liver enzymes

Low: Gastrointestinal upset; allergic or skin reactions

Speculative: Effects in pregnancy; central nervous system overstimulation

Monitoring

Marker	Target	Why
ALT (alanine aminotransferase)	~10–25 U/L	Tracks liver-cell health and hepatoprotective response
AST (aspartate aminotransferase)	~10–25 U/L	Complements ALT for liver status
Fasting plasma glucose	70–90 mg/dL	Assesses the glycemic-control goal
HbA1c (glycated hemoglobin)	<5.4%	Confirms sustained glucose effect
LDL cholesterol	<100 mg/dL (lower if higher-risk)	One trial showed LDL reduction with Schisandra extract
Kupperman Index / menopause symptom score	Lower score = fewer symptoms	Quantifies menopausal-symptom benefit

Cadence: Baseline, again at 8–12 weeks, then every 6–12 months if use continues; those combining with interacting medications monitor drug levels per their physician's schedule.

Qualitative Assessment

Perceived energy and physical stamina through the day
Stress resilience and mood under load
Sleep quality and whether dosing timing disturbs it
Frequency and severity of hot flushes, sweating, or palpitations (for menopausal use)
Digestive comfort (absence of reflux or stomach upset)

Schisandra for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment